Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 2/2008

01-03-2008

Small bowel infarcts in Degos disease

Authors: Raghu R. Amaravadi, Tai M. Tran, Rachel Altman, Christopher D. Scheirey

Published in: Abdominal Radiology | Issue 2/2008

Login to get access

Abstract

Degos disease is a rare idiopathic vasculopathy with multisystem involvement. We present a previously healthy 40-year-old woman who developed spontaneous small bowel infarctions and perforations 17 months after presentation with characteristic skin lesions. The abdominal CT findings of Degos disease, which have not been previously depicted in the radiology literature, are discussed.
Literature
1.
Kohlmeier W (1941) Multiple Hauntnekrosen bei thromboangiitis obiterans. Arch Dermatol Syphilol 181:783–792CrossRef
2.
Degos R, Delort J, Tricot R (1942) Dermatite papulosquameuse atrophiante. Bull Soc Fr Dermatol Syphiligr 49:148–150
3.
Feuerman EJ, Dollberg L, Salvador O (1970) Malignant atrophic papulosis with mucin in the dermis. A clinical and pathological study, including autopsy. Arch Pathol 90:310–315PubMed
4.
Nomland R, Layton JM (1960) Malignant papulosis with atrophy (Degos); fatal cutaneointestinal syndrome. Arch Dermatol 81:181–188PubMed
5.
Dastur DK, Singhal BS, Shroff HJ (1981) CNS involvement in malignant atrophic papulosis (Kohlmeier–Degos disease): vasculopathy and coagulopathy. J Neurol Neurosurg Psychiatry 44:156–160PubMed
6.
Amato C, Ferri R, Elia M, et al. (2005) Nervous system involvement in Degos disease. AJNR Am J Neuroradiol 26:646–649PubMed
7.
Fernandez-Perez ER, Grabscheid E, Scheinfeld NS (2005) A case of systemic malignant atrophic papulosis (Kohlmeier–Degos disease). J Natl Med Assoc 97:421–425PubMed
8.
Yukiiri K, Mizushige K, Ueda T, et al. (2000) Degos disease with constrictive pericarditis: a case report. Jpn Circ J 64:464–467PubMedCrossRef
9.
Magrinat G, Kerwin KS, Gabriel DA (1989) The clinical manifestations of Degos syndrome. Arch Pathol Lab Med 113:354–362PubMed
10.
Casparie MK, Meyer JW, van Huystee BE, et al. (1991) Endoscopic and histopathologic features of Degos disease. Endoscopy 23:231–233PubMedCrossRef
11.
Bilbao JI, Garcia Delgado F, Idoate M, et al. (1986) Degos syndrome. Intestinal involvement as demonstrated by digital angiography: a case. J Radiol 67:711–713PubMed
12.
Strole WE Jr, Clark WH Jr, Isselbacher KJ (1967) Progressive arterial occlusive disease (Kohlmeier-Degos). A frequently fatal cutaneosystemic disorder. N Engl J Med 276:195–201PubMedCrossRef
13.
14.
Burg G, Vieluf D, Stolz W, et al. (1989) Malignant atrophic papulosis (Kohlmeier–Degos disease). Hautarzt 40:480–485PubMed
15.
Ball E, Newburger A, Ackerman AB (2003) Degos disease: a distinctive pattern of disease, chiefly of lupus erythematosus, and not a specific disease per se. Am J Dermatopathol 25:308–320PubMedCrossRef
16.
Scheinfeld N (2005) Degos disease is probably a distinct entity: a review of clinical and laboratory evidence. J Am Acad Dermatol 52:375–376; author reply 376–378
Metadata
Title
Small bowel infarcts in Degos disease
Authors
Raghu R. Amaravadi
Tai M. Tran
Rachel Altman
Christopher D. Scheirey
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 2/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9225-1

Other articles of this Issue 2/2008

Abdominal Radiology 2/2008 Go to the issue

OriginalPaper

Intestinal parasitic infection

OriginalPaper

Esophageal achalasia: comparison of fluoroscopically-guided double vs. endoscopically-guided single balloon dilation

OriginalPaper

RFA of renal cell carcinoma in a solitary kidney

OriginalPaper

Testicular teratocarcinoma associated with testicular microlithiasis

OriginalPaper

Leiomyosarcoma of the infrarenal portion of the inferior vena cava in a cirrhotic patient with hepatitis C

OriginalPaper

Ancient schwannoma of the female pelvis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits